Watch this Webinar on-demand!
Part 1
Part 2
This webinar is made possible by an educational grant provided by Millicent Services Inc.
Objectives:
- Recall the history of the use of hormones for the treatment of women with VVA/GSM
- Identify the safety data of treatments for VVA/GSM
- Characterize the hormone receptors found in the vestibule and vagina
- Associate treatment options based on vaginal and vestibular physiology
CME credits will be available for viewing the webinar. CLICK HERE for CME information.
![Rachel Rubin](/images/pic-for-web/board/rachel-rubin-headshot__416x416.png)
Rachel RubinMD, IF
Moderator
Moderator
![Irwin Goldstein](/images/pic-for-web/board/Goldstein.I.png)
Irwin GoldsteinMD, IF
Panelist
Panelist
![Noel Kim](/images/pic-for-web/board/Kim.N.png)
Noel KimPhD, IF
Panelist
Panelist
![Tami Rowen](/images/2021/03/06/tami.rowen.png)
Tami RowenMD, MS, FACOG, IF
Panelist
Panelist
![James Simon](/images/pic-for-web/board/Simon.J.png)
James SimonMD, CCD, NCMP, FACOG, IF
Panelist
Panelist
Program Outline:
PART I:
08:00
Introduction of ISSWSH and faculty
Rachel Rubin
8:05
History of treatments for VVA/GSM
Tami Rowen
8:15
Physiology of the vagina and vestibule: estrogens and androgens
Noel Kim
PART II:
8:30
Use and safety of local estradiol in the wake of the WHI
James Simon
8:40
Current vaginal therapies: efficacy based on physiology
Irwin Goldstein
8:55
Q & A
Moderator Rachel Rubin